Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 1;14(4):319.
doi: 10.3390/ph14040319.

Implementation of an Enzyme Membrane Reactor to Intensify the α- O-Glycosylation of Resveratrol Using Cyclodextrins

Affiliations

Implementation of an Enzyme Membrane Reactor to Intensify the α- O-Glycosylation of Resveratrol Using Cyclodextrins

Irina Ioannou et al. Pharmaceuticals (Basel). .

Abstract

The O-glycosylation of resveratrol increases both its solubility in water and its bioavailability while preventing its oxidation, allowing a more efficient use of this molecule as a bioactive ingredient in pharmaceutical and cosmetic applications. Resveratrol O-glycosides can be obtained by enzymatic reactions. Recent developments have made it possible to selectively obtain resveratrol α-glycosides from the β-cyclodextrin-resveratrol complex in water with a yield of 35%. However, this yield is limited by the partial hydrolysis of the resveratrol glycosides produced during the reaction. In this study, we propose to intensify this enzymatic reaction by coupling the enzymatic reactor to a membrane process. Firstly, membrane screening was carried out at the laboratory scale and led to the choice of a GE polymeric membrane with a cut-off of 1 kDa. This membrane allowed the retention of 65% of the β-cyclodextrin-resveratrol complex in the reaction medium and the transfer of 70% of the resveratrol α-O-glycosides in the permeate. In a second step, this membrane was used in an enzymatic membrane reactor and improved the yield of the enzymatic glycosylation up to 50%.

Keywords: cyclodextrins; enzymatic O-glycosylation; enzyme membrane reactor; process intensification; resveratrol.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Retention rates according to the transmembrane pressure for GE and GH membranes.
Figure 2
Figure 2
Retention rates for complexed resveratrol and piceid with regards to the transmembrane pressure for (a) GE, (b) GH and (c) PT membranes.
Figure 3
Figure 3
Molar yield of the α-O-glycoside of resveratrol in the permeate during the α-O-glycosylation reaction with the GE and GH membranes.
Figure 4
Figure 4
Retention rates (a,b) and molar yields of glycosides (c,d) obtained in the coupling of the extractive reaction with GE and GH membranes.
Figure 5
Figure 5
Optimal complex geometries in the case of resveratrol (left, binding energy = −5.32 kcal/mol) and piceid (right, binding energy = −5.24 kcal/mol).
Figure 6
Figure 6
α-O-glycosylation reaction of resveratrol with β-cyclodextrin.
Figure 7
Figure 7
METCell filtration system (a) in cross-flow and (b) in dead-end configuration.
Figure 8
Figure 8
Enzyme membrane reactor used to intensify resveratrol glycosylation.

References

    1. Baxter R.A. Anti-aging properties of resveratrol: Review and report of a potent new antioxidant skin care formulation. J. Cosmet. Dermatol. 2008;7:2–7. doi: 10.1111/j.1473-2165.2008.00354.x. - DOI - PubMed
    1. Ratz-Łyko A., Arct J. Resveratrol as an active ingredient for cosmetic and dermatological applications: A review. J. Cosmet. Laser Ther. 2019;21:84–90. doi: 10.1080/14764172.2018.1469767. - DOI - PubMed
    1. Oi N., Jeong C.-H., Nadas J., Cho Y.-Y., Pugliese A., Bode A.M., Dong Z. Resveratrol, a Red Wine Polyphenol, Suppresses Pancreatic Cancer by Inhibiting Leukotriene A4 Hydrolase. Cancer Res. 2010;70:9755–9764. doi: 10.1158/0008-5472.CAN-10-2858. - DOI - PMC - PubMed
    1. Tellone E., Galtieri A., Russo A., Giardina B., Ficarra S. Resveratrol: A Focus on Several Neurodegenerative Diseases. Oxid. Med. Cell. Longev. 2015;2015:1–14. doi: 10.1155/2015/392169. - DOI - PMC - PubMed
    1. Qiao Y., Gao K., Wang Y., Wang X., Cui B. Resveratrol ameliorates diabetic nephropathy in rats through negative regulation of the p38 MAPK/TGF-β1 pathway. Exp. Ther. Med. 2017;13:3223–3230. doi: 10.3892/etm.2017.4420. - DOI - PMC - PubMed

LinkOut - more resources